Insider Transactions in Q2 2023 at Kinnate Biopharma Inc. (KNTE)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Neha Krishnamohan CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,459
-2.09%
|
$5,836
$4.3 P/Share
|
|
Jun 01
2023
|
Mark A Meltz COO GENERAL COUNSEL SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-1.82%
|
$2,164
$4.3 P/Share
|
|
Jun 01
2023
|
Richard Thomas Williams CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-0.78%
|
$2,164
$4.3 P/Share
|
|
May 08
2023
|
James B. Tananbaum |
BUY
Open market or private purchase
|
Indirect |
1,780,000
+30.55%
|
$3,560,000
$2.8 P/Share
|
|
May 08
2023
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,780,000
+30.55%
|
$3,560,000
$2.8 P/Share
|
|
May 05
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
981,023
+26.39%
|
$1,962,046
$2.82 P/Share
|
|
May 05
2023
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
981,023
+26.39%
|
$1,962,046
$2.82 P/Share
|
|
May 04
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
479,909
+7.85%
|
$959,818
$2.75 P/Share
|
|
May 04
2023
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
479,909
+7.85%
|
$959,818
$2.75 P/Share
|
|
May 02
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
338,262
+6.18%
|
$676,524
$2.67 P/Share
|
|
May 02
2023
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
338,262
+6.18%
|
$676,524
$2.67 P/Share
|
|
May 01
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
716,157
+12.99%
|
$1,432,314
$2.62 P/Share
|
|
May 01
2023
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
716,157
+12.99%
|
$1,432,314
$2.62 P/Share
|
|
Apr 28
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
350,749
+7.97%
|
$701,498
$2.55 P/Share
|
|
Apr 28
2023
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
350,749
+7.97%
|
$701,498
$2.55 P/Share
|